LGR4 and ovarian cancer: Here, our results reported that LGR6, not LGR4 or LGR5, was dramatically upregulated in ovarian cancer tissues, and overexpression of LGR6 significantly correlated with poor clinicopathological characteristics, as well as predicted poor overall and progression-free survival in ovarian cancer patients.